Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Younger girls recognized with breast most cancers expertise vital declines in physique picture, sexual satisfaction, and sexual curiosity each throughout and after...
Dr. Vishal A. Patel, a Mohs surgeon and dermato-oncologist at George Washington College, explains that Libtayo (cemiplimab-rwlc)’s new FDA approval supplies sufferers...
